Pharmacological Strategies For The Prevention Of Acute Kidney Injury Following Cardiac Surgery: An Overview Of Systematic Reviews

ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)


Volume 20, 42 Issues, 2014


Download PDF Flyer




Current Pharmaceutical Design

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 65th of 261 in Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
William A. Banks
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.311
5 - Year: 3.696

Pharmacological Strategies For The Prevention Of Acute Kidney Injury Following Cardiac Surgery: An Overview Of Systematic Reviews

Author(s): Nishith N Patel and Gianni D Angelini

Affiliation: Level 7, Queen’s Building, Bristol Heart Institute, Bristol Royal Infirmary, Marlborough Street, Bristol. United Kingdom. BS2 8HW

Abstract

Context: Post cardiac surgery acute kidney injury (AKI) is common, poorly understood and associated with a significant increase in morbidity and mortality.

Objectives: An overview of systematic reviews that have evaluated pharmacological agents for the prevention of AKI post cardiac surgery. Data Sources: We searched electronic databases (PubMed and the Cochrane Database of Systematic Reviews) from inception to January 2014.

Study Selection: Systematic reviews of randomized controlled trials that have evaluated pharmacological agents for the prevention of AKI in adult patients undergoing cardiac surgery.

Data Analysis: Numbers needed to treat (NNT) or harm (NNH) were calculated from pooled events given in each meta-analysis. Primary outcome measures were defined as (i) mortality, (ii) need for renal replacement therapy (RRT), and (iii) acute kidney injury.

Results: Data from 7 systematic reviews evaluating 6 different pharmacological renoprotective agents were included. Dopamine, fenoldopam and N-acetylcysteine did not demonstrate any benefit in terms of mortality, need for RRT or incidence of AKI. Atrial natriuretic peptide reduced the need for RRT (NNT = 22 (95% CI: 13 to 73) and brain natriuretic peptide reduced the incidence of AKI (NNT = 11 (95% CI: 6 to 32), although both agents did not demonstrate any effect on mortality. Loop diuretics demonstrated increased incidence of AKI (NNH = 8 (95% CI: 5 to 15).

Conclusion: There is a paucity of effective renoprotective agents that can be used in adult cardiac surgical patients. There is an urgent need to develop novel renoprotective strategies.


Keywords: Surgery, Cardiopulmonary Bypass, Kidney, Drugs, Prevention, Meta-Analysis, Overview

Purchase Online Rights and Permissions

Article Details

Volume: 20
First Page: 1
Last Page: 5
Page Count: 5
DOI: 10.2174/1381612820666140325113422
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science